UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Journal of bone and mineral research, 2005-09, Vol.20 (9), p.1514-1524

2005

Volltextzugriff (PDF)

RANKL Inhibition With Denosumab Does Not Influence 3‐Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk

Journal of bone and mineral research, 2014-02, Vol.29 (2), p.450-457

2014

Volltextzugriff (PDF)

A Distinct Cation‐Sensing Mechanism in MC3T3‐E1 Osteoblasts Functionally Related to the Calcium Receptor

Journal of bone and mineral research, 1997-03, Vol.12 (3), p.393-402

1997

Volltextzugriff (PDF)

Molecular to pharmacologic control of osteoblast proliferation and differentiation

Journal of cellular biochemistry, 1994-07, Vol.55 (3), p.310-320

1994

Volltextzugriff (PDF)

Differential regulation of receptor‐stimulated cyclic adenosine monophosphate production by polyvalent cations in MC3T3‐E1 osteoblasts

Journal of bone and mineral research, 1996-06, Vol.11 (6), p.789-799

1996

Volltextzugriff (PDF)

Nonmyristoylated MARCKS Complements Some but Not All of the Developmental Defects Associated with MARCKS Deficiency in Mice

Developmental biology, 1996-10, Vol.179 (1), p.135-147

1996

Volltextzugriff (PDF)

Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts

Endocrinology (Philadelphia), 1995-11, Vol.136 (11), p.4834-4841

1995

Volltextzugriff (PDF)

Okadaic acid-sensitive protein phosphatases dephosphorylate MARCKS, a major protein kinase C substrate

FEBS letters, 1993-12, Vol.336 (1), p.37-42

1993

Volltextzugriff (PDF)

Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: Minimal role of the proximal E-box cis-acting promoter elements

Journal of cellular biochemistry, 1997-04, Vol.65 (1), p.11-24

1997

Volltextzugriff (PDF)

Influence of Dietary Fat on Factors in Serum That Regulate Thyroid Cell Metabolism

The Journal of nutrition, 1990-11, Vol.120 (11), p.1297-1304

1990

Volltextzugriff (PDF)

Toxicity of Palmitoyl Glycerol to Mice: Hypothermia and Reversal of the Toxicity

The Journal of nutrition, 1987-10, Vol.117 (10), p.1671-1675

1987

Volltextzugriff (PDF)

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2009-08, Vol.361 (8), p.756-765

2009

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3161-3169

2012

Volltextzugriff (PDF)

Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis

Journal of bone and mineral research, 2012-01, Vol.27 (1), p.211-218

2012

Volltextzugriff (PDF)

Two‐Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

Journal of bone and mineral research, 2007-12, Vol.22 (12), p.1832-1841

2007

Volltextzugriff (PDF)

Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone

Pain medicine (Malden, Mass.), 2018-02, Vol.19 (2), p.307-318

2018

Volltextzugriff (PDF)

A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial

The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1335-1342

2015

Volltextzugriff (PDF)

A pharmacological review of selective oestrogen receptor modulators

Human reproduction update, 2000-05, Vol.6 (3), p.212-224

2000

Volltextzugriff (PDF)

Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy

Obstetrics and gynecology (New York. 1953), 2003-02, Vol.101 (2), p.346-352

2003

Volltextzugriff (PDF)

The Effect of Selective Estrogen Receptor Modulators on Parameters of the Hypothalamic-Pituitary-Gonadal Axis

Annals of the New York Academy of Sciences, 2001-12, Vol.949 (1), p.251-258

2001

Volltextzugriff (PDF)

Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis

Obstetrical & gynecological survey, 2009-12, Vol.64 (12), p.805-807

2009

Volltextzugriff (PDF)

Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms

Obstetrics and gynecology (New York. 1953), 2004-02, Vol.103 (2), p.267-273

2004

Volltextzugriff (PDF)

Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity

Fertility and sterility, 2002-09, Vol.78 (3), p.469-472

2002

Volltextzugriff (PDF)

Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia

Metabolism, clinical and experimental, 2005-07, Vol.54 (7), p.939-946

2005

Volltextzugriff (PDF)

Apharmacological review of selective oestrogen receptor modulators

Human reproduction update, 2000-05, Vol.6 (3), p.212-224

2000

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(16)
Biological And Medical Sciences
(13)
Female
(13)
Aged
(11)
Middle Aged
(11)
Endocrinology & Metabolism
(10)
Aged, 80 And Over
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Double-Blind Method
(7)
Male
(7)
Adult
(6)
Animals
(6)
Denosumab
(6)
Medical Sciences
(6)
Mice
(6)
Osteoporosis, Postmenopausal - Drug Therapy
(6)
Bone Density - Drug Effects
(5)
Osteoporosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

RANKL Inhibition With Denosumab Does Not Influence 3‐Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk

A Distinct Cation‐Sensing Mechanism in MC3T3‐E1 Osteoblasts Functionally Related to the Calcium Receptor

Molecular to pharmacologic control of osteoblast proliferation and differentiation

Differential regulation of receptor‐stimulated cyclic adenosine monophosphate production by polyvalent cations in MC3T3‐E1 osteoblasts

Nonmyristoylated MARCKS Complements Some but Not All of the Developmental Defects Associated with MARCKS Deficiency in Mice

Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts

Okadaic acid-sensitive protein phosphatases dephosphorylate MARCKS, a major protein kinase C substrate

Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: Minimal role of the proximal E-box cis-acting promoter elements

Influence of Dietary Fat on Factors in Serum That Regulate Thyroid Cell Metabolism

Toxicity of Palmitoyl Glycerol to Mice: Hypothermia and Reversal of the Toxicity

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density

Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis

Two‐Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone

A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial

A pharmacological review of selective oestrogen receptor modulators

Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy

The Effect of Selective Estrogen Receptor Modulators on Parameters of the Hypothalamic-Pituitary-Gonadal Axis

Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis

Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms

Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity

Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia

Apharmacological review of selective oestrogen receptor modulators

Suchergebnisse filtern